A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Drug treatment for spinal muscular atrophy types II and IIITreatment for cramps in amyotrophic lateral sclerosis/motor neuron diseaseDrug treatment for spinal muscular atrophy types II and IIITreatment for familial amyotrophic lateral sclerosis/motor neuron diseaseDrug treatment for spinal muscular atrophy types II and IIIAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAntioxidant treatment for amyotrophic lateral sclerosis or motor neuron diseaseAntioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseTreatment for familial amyotrophic lateral sclerosis/motor neuron diseaseTreatment for cramps in amyotrophic lateral sclerosis/motor neuron diseaseA comprehensive review of amyotrophic lateral sclerosisComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisOxidative Stress in Neurodegenerative DiseasesTempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) formsClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisReprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytesThe PRO-ACT database: design, initial analyses, and predictive featuresALS issues in clinical trials. Missing data.Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent.An in vitro screening cascade to identify neuroprotective antioxidants in ALSVitamin E and all-cause mortality: a meta-analysis.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis.Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.Unleashing the untold and misunderstood observations on vitamin E.A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.Progress in therapy development for amyotrophic lateral sclerosisVitamin E and neurodegenerative disorders associated with oxidative stress.Therapeutic developments in the treatment of amyotrophic lateral sclerosis.Antioxidants as treatment for neurodegenerative disorders.Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the AmInduced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Oxidative stress and nitration in neurodegeneration: cause, effect, or association?Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics.Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials.
P2860
Q21090716-D64D23FB-C002-499B-9713-23F5B2CC99C0Q24200270-075BF908-E31A-433D-95B5-6D78A67CCFBCQ24200285-B7145C3E-9252-4227-89E0-398EEDE00D70Q24234414-6A2ADB6A-92C1-44F6-B4E9-1DC01EB932ADQ24241570-0DB90856-4F02-47B7-A224-EB57821212D5Q24241759-9DCFC748-7832-4AF2-856F-C4A1F00D5823Q24242944-C9263A11-F1F6-4071-BFFA-56127CAFAFD7Q24243199-5923F283-E5C1-461C-98E2-D00853EB2D9BQ24244879-82968590-9F33-46E0-BDBF-8D07F83F2F3FQ24245711-055A87D7-AAC7-4875-A4A8-9FF5B7745F25Q24250095-A24F8A98-EAAD-4EF8-B37B-864CD2EBF507Q26775401-2E26B04F-5045-47D0-802E-71273E6C8194Q26777929-3EC975EF-BECD-4981-B2CE-6A910B9070C6Q26801239-67D83CB3-E965-445B-A70A-541302FB609AQ27315986-78AD2053-796C-49CE-A578-50E5EC446EBCQ28392768-93EDC04E-2684-47D0-98C7-1D48067F2C74Q28544716-57E0AEBD-AC3C-477D-9BE2-81D9AE445AA3Q28651661-5E7F17E7-AB11-4722-B808-5D10315D80EBQ30974065-865CAF64-4336-44B9-AFA6-8CE8EEE4CB55Q31130991-843BE41D-3B56-42BF-9904-80D14E1CB9D8Q33445432-8AEF2A72-23A7-4D1B-BBB5-E3847433A5EEQ33649141-28ACEB85-5302-47A1-AB55-D04177B063BAQ33783000-4BC6275A-75CC-4D95-A413-AE92F464D44EQ33824784-18B22D84-A570-426F-94B3-D1DD4E584725Q34104378-B8558094-339A-43DA-AF8E-64590903EDC6Q34401653-117C4838-6BEA-42AE-8FDF-5EF8F33AF6E8Q34455748-2F071B15-51DF-4B81-859E-12F17C5DA3EFQ34571459-910CE061-CF10-4B1B-9500-6CF47396BC4BQ34581614-D8D2D57C-786B-4A91-8920-8E087155179DQ34593882-DD94D118-07BB-4CC5-851A-521BA2A60856Q34640800-68778122-781C-4A6D-B955-9C033A62F023Q34777721-03CBD913-E035-4C3C-BBC5-A4F1BCD0A36EQ34974850-20C1020B-5FEE-437D-BD4D-935E1F63778CQ34974866-2203DCDF-CFCF-4B40-93B8-E8484C5F3313Q35007618-07560344-B8CC-40E6-AA33-75312ADF7B19Q35037783-2B5AAAAC-DC50-4E3B-B9F4-2D5F55973080Q35047296-9598AA39-9EA7-48B4-A4E6-60F5844F6BFBQ35116171-90FBD7E2-6B53-4724-A66F-EAAC54B8C31EQ35630224-9B11C0D4-5CE1-4223-AE88-00FD44B4F58CQ35671076-5B5A6D9E-D039-450D-A2B9-D262FAEE806E
P2860
A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@en
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@nl
type
label
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@en
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@nl
prefLabel
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@en
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@nl
P2093
P921
P1476
A double-blind, placebo-contro ...... luzole-tocopherol Study Group.
@en
P2093
P356
10.1080/146608201300079364
P577
2001-03-01T00:00:00Z